HNASX
Price
$20.36
Change
-$0.07 (-0.34%)
Updated
Sep 5 closing price
Net Assets
432.04M
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

HNASX vs RGEBX

Header iconHNASX vs RGEBX Comparison
Open Charts HNASX vs RGEBXBanner chart's image
Homestead Growth
Price$20.36
Change-$0.07 (-0.34%)
VolumeN/A
Net Assets432.04M
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
HNASX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HNASX vs. RGEBX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNASX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. HNASX (432M). HNASX (0.00) and RGEBX (0.00) have matching dividends . HNASX was incepted earlier than RGEBX: HNASX (25 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than HNASX (0.82). RGEBX is a more actively managed with annual turnover of: 25.00 vs. HNASX (20.00). RGEBX has a lower initial minimum investment than HNASX: RGEBX (250) vs HNASX (500). RGEBX annual gain was more profitable for investors over the last year : 17.32 vs. HNASX (15.55). HNASX (39.84) and RGEBX (38.39) have equivalent 5 years return.
HNASXRGEBXHNASX / RGEBX
Total Expense Ratio0.821.0975%
Annual Report Gross Expense Ratio0.821.0975%
Fund Existence25 years11 years-
Gain YTD10.61215.13270%
Front LoadN/AN/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets432M332B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.5517.3290%
Returns for 3 years76.7357.24134%
Returns for 5 years39.8438.39104%
Returns for 10 years151.3291.00166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc